Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
about
The endocannabinoid system as a target for the treatment of neurodegenerative disease.Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.The therapeutic potential of cannabinoids for movement disorders.Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.The endocannabinoid system as a target for the treatment of motor dysfunction.The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.Prospects for cannabinoid therapies in basal ganglia disorders.Cannabinoids, multiple sclerosis and neuroprotection.A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease.The role of cannabinoids and leptin in neurological diseases.Endocannabinoid system in neurodegenerative disorders.Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: involvement of CB1 and NMDA receptors.Effects of a Sativex-Like Combination of Phytocannabinoids on Disease Progression in R6/2 Mice, an Experimental Model of Huntington's Disease.Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases.Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease.
P2860
Q34098196-EDCC00EF-7E0F-48F3-9031-EE68582A8D93Q34440282-9559C7A1-103D-4165-A269-F54A10443951Q35171113-9420C575-4A3D-4944-8547-06D8F4779B84Q36056302-7FCD8F70-3F05-44E0-98B3-010295DD9C41Q36341688-D905500B-B3EE-4D1C-8F16-CCDCAD84190EQ37253331-9E1C99F5-4C82-4D30-B53E-E50E71EE9A30Q37394164-C74323C5-6390-4B7E-8392-667B7C7ADA20Q37577451-EE217EEE-49C2-4B68-9055-0FDD549E3453Q37872326-0D5F57FE-0A08-43D6-825B-2B922FC1D378Q37960199-E9CC8F64-4CD6-489E-9FBB-EBE43BB8646CQ38392800-39BC4C50-2ADC-4AF4-94C5-DB5C1A688BC9Q38423817-4B5E3BD9-177D-4332-B5B5-91B4545D29FDQ39368845-7CE283A8-FC39-4BED-A6FB-8A58216D776FQ41969953-B9BC9F4A-E3B7-4175-951F-CE2933923DECQ42289980-1E7D1E82-4DE0-4F11-8310-68CB292C6C41Q42478056-A70040CC-7DD2-4185-9A7B-920BA5BAB90CQ42495608-32ECDE65-C6F9-4D9D-A22F-A32C0B3766BAQ45303268-817945FE-CDCA-475E-91A4-90DE5314BA4A
P2860
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
@en
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
@nl
type
label
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
@en
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
@nl
prefLabel
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
@en
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
@nl
P2093
P921
P1433
P1476
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo
@en
P2093
Frédéric Boyer
Javier Fernández-Ruiz
Nicolas Bizat
Philippe Hantraye
P304
P356
10.1097/00001756-200410250-00015
P577
2004-10-01T00:00:00Z